1. Kohno N, Akiyama M, Kyoizumi S et al (1988) Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18(3):203–216
2. Kohno N (1999) Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 46(3–4):151–158
3. Miyazaki M, Ohtsuka M, Miyakawa S et al (2015) Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci 22(3):181–196
4. International Union Against Cancer (UICC): TNM classification of malignant tumours, 8th ed. Brierley JD, Gopodarowicz MK, and Wittekind C, editors. Wiley-Blackwell, Chichester; 2017
5. Kawamoto T, Shoda J, Irimura N et al (2001) Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder. Clin Cancer Res 7(5):1333–1342